Drug Patent Expirations in December 2014

Drug Patent Expirations for December 2014

TradenameApplicantGeneric NamePatent NumberPatent Expiration
TRAVATANAlcon Pharms Ltdtravoprost5,889,052Dec 2, 2014
TRAVATAN ZAlcon Pharms Ltdtravoprost5,889,052Dec 2, 2014
MYLOTARGWyeth Pharms Incgemtuzumab ozogamicin5,693,762Dec 2, 2014
NORVIRAbbottritonavir5,635,523*PEDDec 3, 2014
NOVOLOG FLEXPENNovo Nordisk Incinsulin aspart recombinant5,618,913*PEDDec 7, 2014
NOVOLOG INNOLETNovo Nordisk Incinsulin aspart recombinant5,618,913*PEDDec 7, 2014
NOVOLOG MIX 70/30Novo Nordisk Incinsulin aspart protamine recombinant; insulin aspart recombinant5,618,913*PEDDec 7, 2014
NOVOLOG MIX 70/30 PENFILLNovo Nordisk Incinsulin aspart protamine recombinant; insulin aspart recombinant5,618,913*PEDDec 7, 2014
NOVOLOGNovo Nordisk Incinsulin aspart recombinant5,618,913*PEDDec 7, 2014
NOVOLOG FLEXTOUCHNovo Nordisk Incinsulin aspart recombinant5,618,913*PEDDec 7, 2014
NOVOLOG MIX 50/50Novo Nordisk Incinsulin aspart protamine recombinant; insulin aspart recombinant5,618,913*PEDDec 7, 2014
NOVOLOG MIX 70/30 FLEXPENNovo Nordisk Incinsulin aspart protamine recombinant; insulin aspart recombinant5,618,913*PEDDec 7, 2014
NOVOLOG PENFILLNovo Nordisk Incinsulin aspart recombinant5,618,913*PEDDec 7, 2014
IMAGENTImcor Pharms Codimyristoyl lecithin; perflexane5,695,741Dec 9, 2014
WELCHOLDaiichi Sankyocolesevelam hydrochloride5,919,832*PEDDec 10, 2014
WELCHOLDaiichi Sankyocolesevelam hydrochloride6,433,026*PEDDec 10, 2014
WELCHOLDaiichi Sankyocolesevelam hydrochloride5,607,669*PEDDec 10, 2014
WELCHOLDaiichi Sankyocolesevelam hydrochloride6,066,678*PEDDec 10, 2014
OFEVBoehringer Ingelheimnintedanib6,762,180Dec 10, 2014
RELENZAGlaxosmithklinezanamivir6,294,572Dec 15, 2014
IONSYSIncline Therapfentanyl hydrochloride5,697,896Dec 16, 2014
SANDOSTATIN LARNovartisoctreotide acetate5,639,480*PEDDec 17, 2014
TRAVATANAlcon Pharms Ltdtravoprost5,631,287Dec 22, 2014
TRAVATANAlcon Pharms Ltdtravoprost5,849,792Dec 22, 2014
TRAVATANAlcon Pharms Ltdtravoprost6,011,062Dec 22, 2014
LETAIRISGileadambrisentan5,703,017Dec 30, 2014
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.

Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: